FI833205A7 - Menetelmä hepatitis B-virusrokotteen valmistamiseksi. - Google Patents

Menetelmä hepatitis B-virusrokotteen valmistamiseksi. Download PDF

Info

Publication number
FI833205A7
FI833205A7 FI833205A FI833205A FI833205A7 FI 833205 A7 FI833205 A7 FI 833205A7 FI 833205 A FI833205 A FI 833205A FI 833205 A FI833205 A FI 833205A FI 833205 A7 FI833205 A7 FI 833205A7
Authority
FI
Finland
Prior art keywords
hepatitis
preparing
virus vaccine
vaccine
virus
Prior art date
Application number
FI833205A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI833205L (fi
FI833205A0 (fi
Inventor
Theresa Cabezon
Wilde Michael De
Nigel Harford
Marjolene Crabeel
Original Assignee
Smith Kline Rit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline Rit filed Critical Smith Kline Rit
Publication of FI833205A0 publication Critical patent/FI833205A0/fi
Publication of FI833205L publication Critical patent/FI833205L/fi
Publication of FI833205A7 publication Critical patent/FI833205A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI833205A 1982-09-08 1983-09-07 Menetelmä hepatitis B-virusrokotteen valmistamiseksi. FI833205A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41578982A 1982-09-08 1982-09-08

Publications (3)

Publication Number Publication Date
FI833205A0 FI833205A0 (fi) 1983-09-07
FI833205L FI833205L (fi) 1984-03-09
FI833205A7 true FI833205A7 (fi) 1984-03-09

Family

ID=23647197

Family Applications (1)

Application Number Title Priority Date Filing Date
FI833205A FI833205A7 (fi) 1982-09-08 1983-09-07 Menetelmä hepatitis B-virusrokotteen valmistamiseksi.

Country Status (22)

Country Link
EP (1) EP0106828B1 (enExample)
JP (5) JPS5971694A (enExample)
KR (1) KR840006014A (enExample)
AT (1) ATE91718T1 (enExample)
AU (4) AU584580B2 (enExample)
CA (1) CA1222707A (enExample)
CY (1) CY1932A (enExample)
DE (1) DE3382704T2 (enExample)
DK (1) DK406483A (enExample)
ES (4) ES8506350A1 (enExample)
FI (1) FI833205A7 (enExample)
GR (1) GR78982B (enExample)
HK (1) HK1004570A1 (enExample)
HU (1) HU196625B (enExample)
IE (1) IE60387B1 (enExample)
IL (1) IL69202A (enExample)
MA (1) MA19895A1 (enExample)
MY (1) MY102920A (enExample)
NO (1) NO833198L (enExample)
NZ (1) NZ204952A (enExample)
PT (1) PT77265B (enExample)
ZA (1) ZA836658B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5936699A (ja) * 1982-08-20 1984-02-28 Chemo Sero Therapeut Res Inst シヤトルベクタ−
JPS5931799A (ja) * 1982-08-16 1984-02-20 Science & Tech Agency Ｂ型肝炎ウイルス遺伝子を組込んだ組換えプラスミド
WO1986007384A1 (fr) * 1985-06-03 1986-12-18 Takeda Chemical Industries, Ltd. Procede de preparation de l'antigene p31 de surface du virus de l'hepatite b
WO1986003411A1 (fr) * 1984-12-12 1986-06-19 Takeda Chemical Industries, Ltd. Procede de preparation d'une nouvelle proteine
WO1986001534A1 (fr) * 1984-09-04 1986-03-13 Takeda Chemical Industries, Ltd. Adn recombinant et son utilisation
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them
DE3677851D1 (de) * 1985-08-05 1991-04-11 Merck & Co Inc Verfahren zur steigerung der produktion von rekombinantem protein in hefearten der gattung saccharomyces.
US4895800A (en) * 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen
ZA88488B (en) * 1987-01-30 1988-10-26 Smith Kline Rit Hepatitis b virus surface antigens and hybrid antigens containing them
ATE93891T1 (de) * 1987-03-09 1993-09-15 Merck & Co Inc Reinigung von rekombiniertem hepatitis-boberfl|chen-antigen.
NZ229260A (en) * 1988-06-03 1994-02-25 Merck & Co Inc Hepatitis b virus, expression cassette for pre-s domain, host cells and
US4962656A (en) * 1989-06-30 1990-10-16 The United States Of America As Represented By The United States Department Of Energy Control and monitoring method and system for electromagnetic forming process
LT3988B (en) 1992-02-17 1996-06-25 Fermentas Biotech Inst Recombinant plasmides pfs19, pfps2-48 and pjlfds1 codingsynthesis of human hepatite b of surfice virus antigenes, methods fof producing thereof
TW340132B (en) * 1994-10-20 1998-09-11 Ibm Structure for use as an electrical interconnection means and process for preparing the same
JP4028850B2 (ja) * 2004-02-04 2007-12-26 株式会社名機製作所 ディスク基板の成形用金型

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU44186B (en) * 1978-12-22 1990-04-30 Biogen Nv Process for obtaining recombinant dnk molecules
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
GR76274B (enExample) * 1981-08-04 1984-08-04 Univ California
NZ201705A (en) * 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
GB2125047B (en) * 1982-08-09 1986-02-19 Ciba Geigy Ag Yeast hybrid vectors and their use for the production of polypeptides

Also Published As

Publication number Publication date
AU584580B2 (en) 1989-06-01
KR840006014A (ko) 1984-11-21
JP2522825B2 (ja) 1996-08-07
ES532732A0 (es) 1985-10-16
ZA836658B (en) 1984-06-27
GR78982B (enExample) 1984-10-02
FI833205L (fi) 1984-03-09
JPH08317796A (ja) 1996-12-03
NO833198L (no) 1984-03-09
EP0106828A3 (en) 1985-11-21
JPH02116A (ja) 1990-01-05
JPH02231084A (ja) 1990-09-13
CA1222707A (en) 1987-06-09
IE832099L (en) 1984-03-08
EP0106828A2 (fr) 1984-04-25
DE3382704T2 (de) 1994-02-10
DK406483D0 (da) 1983-09-07
ES8600938A1 (es) 1985-10-16
CY1932A (en) 1983-09-06
PT77265A (en) 1983-09-01
PT77265B (en) 1986-02-04
MY102920A (en) 1993-03-31
AU9001491A (en) 1992-02-27
ES8602120A1 (es) 1985-11-01
JPS5971694A (ja) 1984-04-23
ES8600939A1 (es) 1985-10-16
IE60387B1 (en) 1994-07-13
ES525439A0 (es) 1985-07-01
ES532730A0 (es) 1985-10-16
DK406483A (da) 1984-03-09
NZ204952A (en) 1986-05-09
ES8506350A1 (es) 1985-07-01
JP2702899B2 (ja) 1998-01-26
IL69202A (en) 1991-08-16
DE3382704D1 (de) 1993-08-26
JPH02464A (ja) 1990-01-05
AU1569288A (en) 1988-07-28
AU3131889A (en) 1989-07-20
HU196625B (en) 1988-12-28
ES532731A0 (es) 1985-11-01
ATE91718T1 (de) 1993-08-15
FI833205A0 (fi) 1983-09-07
EP0106828B1 (fr) 1993-07-21
MA19895A1 (fr) 1984-04-01
AU1675083A (en) 1984-03-15
HK1004570A1 (en) 1998-11-27

Similar Documents

Publication Publication Date Title
AU506385B2 (en) Hepatitis b virus; isolation for vaccines
DK210283D0 (da) Fremgangsmade til fremstilling af plasma, plasmapraeparat og vaccine mod hepatitis
DK149942C (da) Fremgangsmaade til fremstilling af en pasteurellose-vaccine
FI791841A7 (fi) Menetelmä valikoidun proteiinin valmistamiseksi.
PT77977A (en) Process for preparing a coupled h.influenza type b vaccine
FI880428L (fi) Ytantigener av hepatit b virus och hybridantigener innehaollande desamma.
FI830638A7 (fi) Menetelmä glykoproteiinien valmistamiseksi.
EP0111549A4 (en) INACTIVATION OF A LIPID VIRUS.
DK210083D0 (da) Fremgangsmade til fremstilling af 6a,10a-trans-hexahydrodibenzopyranoner
DK183583D0 (da) Fremgangsmade til fremstilling af benzoazacycloalkyl-spiro-imidazolidiner
FI833205L (fi) Foerfarande foer framstaellning av ett hepatitis b-virusvaccin
DK1584A (da) Fremgangsmaade til fremstilling af et gitterkernesandwichelement
DK332683D0 (da) Fremgangsmade til fremstilling af en transfer-faktor for et givet virus
DK333183D0 (da) Fremgangsmade til fremstilling af herpes simplex virusglycoproteiner
DE3377972D1 (en) A process for producing a hepatitis b infection preventing vaccine
DK220983A (da) Fremgangsmaade til fremstilling af et cyclisk peptidderivat benaevnt a-21978c
FI842380A7 (fi) Menetelmä piidioksidin valmistamiseksi.
FI831253A7 (fi) Menetelmä uusien oksatsolijohdosten valmistamiseksi.
FI892683A7 (fi) Menetelmä ei-hyperglykosyloitujen hepatiitti-B-virusproteiinien tuottamiseksi
ZA803845B (en) Polyvalent virus vaccines
DK159309C (da) Fremgangsmaade til fremstilling af 4-metyl-5-alkylthiometyl-imidazoler
DK24083A (da) Fremgangsmaade til fremstilling af 0,0'-dithiodibenzoesyrer
DK221283A (da) Fremgangsmaade til fremstilling af et cyclisk peptidderivat benaevnt a-21978c
DK40883D0 (da) Fremgangsmade til fremstilling af benzothienylallylaminer
EP0198828A4 (en) Infectious bursal disease virus vaccine.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: SMITH KLINE - RIT